Cephalon Financial Statements
Cephalon Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Cephalon Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,974.6 | 1,772.6 | 1,764.1 |
| Gross Profit ($ mil.) | 1,562.3 | 1,430.8 | 1,507.0 |
| Operating Income ($ mil.) | 209.3 | (48.6) | 257.2 |
| Total Net Income ($ mil.) | 222.5 | (191.7) | 144.8 |
| Diluted EPS (Net Income) | 2.92 | (2.88) | 2.08 |
Cephalon Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 549.4 | 547.8 | 547.8 |
| Gross Profit ($ mil.) | 459.0 | 442.4 | 442.4 |
| Operating Income ($ mil.) | 164.3 | 139.1 | 139.1 |
| Total Net Income ($ mil.) | 102.7 | 72.0 | 72.0 |
| Diluted EPS (Net Income) | 1.31 | 1.11 | 1.11 |
Cephalon Stock Quote & Chart
11/05/09 16:00:00 EST •
NASDAQ •
57.91
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Cephalon Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.04 | 3.45 | 6.88 |
| Price/Earnings Ratio | 15.65 | 86.21 | 25.00 |
| Price/Book Ratio | 1.97 | 3.51 | 6.62 |
| Price/Cash Flow Ratio | 18.90 | 17.83 | 42.73 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Cephalon Financial Ratios
Cephalon Competitive Intelligence
| GlaxoSmithKline | Johnson & Johnson | Sepracor | |
|---|---|---|---|
| Annual Sales ($ mil.) | 35,244.6 | 63,747.0 | 1,292.3 |
| Employees | 99,003 | 118,700 | 2,400 |
| Market Cap ($ mil.) | 114,075.5 | 164,026.0 | 2,550.5 |
Competitive Landscape
